Skip to main content
Erschienen in:

Open Access 27.01.2022 | Original Paper

Affective lability and social functioning in severe mental disorders

verfasst von: Margrethe Collier Høegh, Ingrid Melle, Sofie R. Aminoff, Stine Holmstul Olsen, Synve Hoffart Lunding, Torill Ueland, Trine Vik Lagerberg

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 5/2022

Abstract

Social functioning is impaired in severe mental disorders despite clinical remission, illustrating the need to identify other mechanisms that hinder psychosocial recovery. Affective lability is elevated and associated with an increased clinical burden in psychosis spectrum disorders. We aimed to investigate putative associations between affective lability and social functioning in 293 participants with severe mental disorders (schizophrenia- and bipolar spectrum), and if such an association was independent of well-established predictors of social impairments. The Affective Lability Scale (ALS-SF) was used to measure affective lability covering the dimensions of anxiety-depression, depression-elation and anger. The interpersonal domain of the Social Functioning Scale (SFS) was used to measure social functioning. Correlation analyses were conducted to investigate associations between affective lability and social functioning, followed by a hierarchical multiple regression and follow-up analyses in diagnostic subgroups. Features related to premorbid and clinical characteristics were entered as independent variables together with the ALS-SF scores. We found that higher scores on all ALS-SF subdimensions were significantly associated with lower social functioning (p < 0.005) in the total sample. For the anxiety-depression dimension of the ALS-SF, this association persisted after controlling for potential confounders such as premorbid social functioning, duration of untreated illness and current symptoms (p = 0.019). Our results indicate that elevated affective lability may have a negative impact on social functioning in severe mental disorders, which warrants further investigation. Clinically, it might be fruitful to target affective lability in severe mental disorders to improve psychosocial outcomes.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1007/​s00406-022-01380-1.

Introduction

Social functioning, defined as the capacity of a person to function in different societal roles such as homemaker, worker, student, partner, family member or friend [1, 2], is an important marker of recovery and a predictor of quality of life in severe mental disorders [3, 4]. Social impairments are present across schizophrenia- and bipolar spectrum disorders and appear to be driven by a range of factors. A better understanding of the different paths leading to social impairment is important to tailor and personalize interventions for the individual patient. Affective disturbances, defined broadly as disruptions in the subjective experience, expressive behavior and physiology of emotions and mood [5], are taxing and highly prioritized as treatment targets by the patients [68]. Several studies have found significant associations between various forms of dysregulated affect and reduced social functioning in patients with both non-affective and affective psychotic disorders [915]. This association appears to be independent of other risk factors such as neurocognitive- and social cognitive deficits, indicating that affective dysregulation may uniquely contribute to social impairments in psychosis. As human emotions are developed, expressed and regulated in interaction with others, it is perhaps not surprising that challenges with affect regulation make social contexts and situations particularly burdensome [16]. Still, there is a paucity of studies investigating the role of specific  facets of affective dysregulation for social functioning in severe mental disorders [17, 18]. Affective lability refers to the propensity to experience rapid, excessive and unpredictable changes in affective states and is associated with poor clinical and functional outcome in many psychiatric disorders [19, 20]. In a sample partially overlapping with that of the current study, we have previously found that affective lability is elevated in schizophrenia- and bipolar spectrum disorders compared to healthy controls [21]; with the highest level in bipolar II disorder (BDII) and equally high levels in schizophrenia and bipolar I disorder (BDI) [22]. Hence, affective lability appears to be a common illness feature across these disorders, with potential consequences for clinical outcome.
To clarify the relationship between affective lability and social functioning in severe mental disorders, other known risk factors for social impairment must be taken into consideration. Predictors of social impairment appear similar across the disorders, and range from individual characteristics through lifetime- and current illness-related features [23, 24]. As social impairment is higher in schizophrenia compared to schizoaffective- and bipolar disorders [23], the presence and/or prominence of psychotic symptoms may be of relevance. This is supported by findings of larger functional impairment in patients with bipolar disorder with psychotic symptoms compared to those without [2527]. Nonetheless, the severity of affective symptoms, depressive in particular, also seems to predict social functioning across diagnoses [2833]. Hence, core clinical symptoms, both current and over the lifetime, appear to be central to social functioning in these populations. In addition, there are several other shared risk factors for social impairments highlighted in the literature. These include male sex [34, 35], poor premorbid social functioning [36, 37], neurocognitive deficits [25, 38], total number of illness episodes [28, 39], duration of untreated illness [40, 41], negative symptoms including apathy [23, 33, 42] and comorbidity such as substance use and anxiety [28, 4346].
Here, we aim to investigate the relationship between affective lability and social functioning in severe mental disorders, and to explore whether this putative relationship is specific to subdimensions of affective lability. To our knowledge, this relationship has not been investigated previously. We hypothesize that affective lability will be associated with social functioning independent of other pre-defined predictors of social impairment across severe mental disorders.

Methods

Participants

The study sample was comprised of two hundred and ninety-three participants with severe mental disorders (schizophrenia [n = 62]; schizophreniform [n = 13]; schizoaffective [n = 16]; BDI [n = 102]; BDII [n = 68]; psychosis Not Otherwise Specified (NOS) [n = 32]), recruited through the Thematically Organized Psychosis (TOP) research study at the Norwegian Center for Mental Disorders Research (NORMENT) in Oslo, Norway. Recruitment to the TOP study is consecutive and still ongoing via psychiatric inpatient and outpatient units in a catchment area that is comprised of all the major hospitals in Oslo. All participants in the study must meet diagnostic criteria for a Diagnostic and Statistical Manual of Mental Disorders 4th Edition (DSM-IV) diagnosis of schizophrenia- or bipolar spectrum disorders and be able to give informed consent. In addition, exclusion criteria are intelligence quotient (IQ) below 70, prior history of severe head trauma and insufficient understanding of a Scandinavian language. In the current study, only participants who had completed the Affective Lability Scale—Short Form (ALS-SF) and the Social Functioning Scale (SFS) were included.
The TOP study has been approved by the Regional Committee for Medical Research Ethics and the Norwegian Data Inspectorate and is conducted in line with the Helsinki declaration of 1975 (as revised in 2008 and 2013).

Diagnostic assessment

The Structured Clinical Interview for DSM-IV axis 1 disorders (SCID; modules A-E) [47] was used to establish diagnoses in the study as part of a thorough clinical assessment carried out by clinical psychologists, medical doctors in psychiatric residency or psychiatrists. All clinical personnel in the study undergo an extensive 3-month training and quality assurance program in the use of SCID and the Positive and Negative Syndrome Scale (PANSS) developed at the University of California, Los Angeles, USA [48] before being allowed to carry out clinical interviews with diagnostic assessments, irrespective of previous clinical training. Diagnostic reliability across different groups of assessment teams have demonstrated a Cohen’s kappa for diagnosis in the range between 0.92 and 0.99.

The Social Functioning Scale (SFS)

The Social Functioning Scale is a self-report scale that was originally developed to measure social adjustment in patients with schizophrenia, tapping areas of functioning that are crucial to community living [49]. It has later been validated for use with other severe mental disorders, including bipolar disorder, and has been found to have sound psychometric properties, as well as to correlate highly with clinician-rated measures of functioning [3, 24, 5053]. The scale is comprised of 76 items that are rated on a Likert scale and yields a total score of overall functioning after illness debut, as well as scores on seven subscales: (1) social engagement/withdrawal (amount of time spent alone, likelihood of initiating conversations, social avoidance); (2) interpersonal behavior (number of friends, romantic relationships, quality of communication); (3) prosocial activities (engagement in common social activities, e.g. going to the cinema); (4) recreation (engagement in hobbies/activities); (5) independence-competence (ability to maintain independent living, e.g. shopping for groceries); (6) independence-performance (performance of skills required for independent living); (7) employment/occupation (or being a full-time student). Each subscale is standardized and normalized to a scaled score (SS) with a mean of 100 and a standard deviation of 15, and the full-scale score is calculated as the mean of the SSs of the seven subscales [49]. The first two subscales combined are referred to as the SFS interpersonal domain. This domain has been found to have good ecological validity and to capture social isolation and social avoidance in particular [54], which are in themselves risk factors for depression, loneliness and other negative health outcomes [16]. The 3rd and 4th subscales comprise the activity domain, and although it includes single items that may reflect social functioning (i.e. whether you have visited friends), it has been found to have low ecological validity [54]. The remaining three subscales are not reflective of social functioning per se, but rather encompass skills for independent living (budgeting, preparing a meal, etc.) and ability to work/study which were not of primary interest in this respect. Consequently, only the interpersonal domain was used for the present study as this domain best represents our outcome measure of interest, namely social functioning. A higher score on the SFS interpersonal domain is indicative of a higher level of functioning.

The Affective Lability Scale Short Form (ALS-SF)

We used the Affective lability Scale Short Form (ALS-SF) [55] to measure affective lability. The scale, which is filled in by the participant, yields a total level of affective lability, in addition to subscores covering fluctuations between three subdimensions; anxiety-depression, depression-elation and anger-normal mood. The scale contains 18 items that are rated on a 4-point Likert scale ranging from 0 (“very uncharacteristic of me”) to 3 (“very characteristic of me”) and has been found to have good psychometric properties [21, 56, 57]. Of the items, five refer to shifts in anxiety-depression, eight refer to shifts in depression-elation and the final five items cover shifts between anger-normal mood. The ALS-SF yields subscores for the three subdimensions in addition to a total score of affective lability (the sum of all item responses divided by 18). In the current study, we chose to investigate the subdimensions in the total sample as opposed to the composite (total) ALS-SF score to more specifically address if there are certain types of affective lability that appear to be linked to social functioning.

Potential confounders of the relationship between social functioning and affective lability

The following variables are previously established predictors of social functioning considered potential confounders of the relationship between social functioning and affective lability in the current analyses. With respect to individual characteristics we investigated: sex, premorbid social functioning based on scores on the social domain in childhood from the Premorbid Adjustment Scale (PAS) [58, 59], as well as overall cognitive ability measured by the Wechsler Abbreviated Scale of Intelligence (WASI, [60]). More specific investigations of the role of cognitive deficits on social functioning were beyond the scope of the current study. Features related to illness course included estimation of duration of illness which was based on the age of onset of the first SCID-verified episode of psychosis for schizophrenia, schizophreniform, schizoaffective and psychosis NOS, and the first SCID-verified affective episode for BDI and BDII. We also calculated an estimate for the duration of untreated illness. For schizophrenia, schizophreniform, schizoaffective and psychosis NOS, duration of untreated psychosis (DUP) was calculated as the number of weeks from the first SCID-verified psychotic episode to adequate treatment (antipsychotic medication in adequate doses/admission to hospital for psychosis). For BDI and BDII, the duration of untreated bipolar disorder (DUB) was based on the number of weeks from the first SCID-verified episode of mania/hypomania to adequate treatment (mood-stabilizing medication or antipsychotics in adequate doses/hospital admission for treatment of mania). DUP and DUB were combined into one variable, duration of untreated illness, to use in the analyses of the whole sample. Further, the total number of illness episodes was calculated as the sum of all recorded illness episodes (depressive, hypomanic, manic, mixed, psychotic). Based on previous indications of a relationship between psychotic symptoms and lower social functioning and since the present sample also included individuals with bipolar disorder who have never had a psychotic episode, a categorical psychosis lifetime variable was made which denoted the lifetime history of a SCID-verified psychotic episode. With respect to current symptom states, they were assessed with the following: positive psychotic symptoms with the positive subscale of the PANSS [61], negative symptoms with the negative subscale of the PANSS, manic symptoms with the Young Mania Rating Scale (YMRS [62]), and depressive symptoms were assessed with the depression item (G6) in the general scale of the PANSS. To measure comorbid anxiety symptoms, the anxiety item (G2) from the general scale of the PANSS was used. These items from the general scale of the PANSS were chosen because they were the only measures of depression and anxiety collected at the same time point as the ALS-SF and the SFS for all participants. We further used the Alcohol Use Disorders Identification Test (AUDIT, [63]) and the Drug Use Disorders Identification Test (DUDIT, [64]) to measure the degree of harmful substance use since associations between reduced social functioning and substance use has previously been found [65, 66].

Statistical analyses

Demographic and clinical characteristics of the sample were investigated with descriptive statistics, including means with standard deviations or frequencies with percentages as fitted. Pearson and Spearman’s correlations were conducted to investigate the relationship between the SFS interpersonal domain and ALS-SF dimensions. Correlational analyses were also performed to investigate the relationship between the SFS interpersonal and demographic as well as clinical variables that have been established as predictors of social functioning in previous research. This was followed by a hierarchical multiple linear regression analysis for the SFS interpersonal score entering all the variables that were significantly associated with the SFS score. The analysis was conducted block-wise to investigate the proportion of variance explained by affective lability specifically. Here, premorbid social adjustment was entered first, the illness course variables (duration of untreated illness, total number of illness episodes) next, followed by the current symptom- and comorbidity variables (positive- and negative symptoms, manic symptoms, depression and anxiety) and finally all of the ALS-SF subdimensions in the last block. There were no indications of problematic multicollinearity between the ALS-SF subdimensions (tolerance ≥ 0.35 and VIF ≤ 2.9 for all dimensions). Based on our previous findings of higher levels of affective lability in BDII versus BDI and schizophrenia [67] and lower levels of social functioning in schizophrenia and psychotic versus non-psychotic bipolar disorder, we anticipated a possible interaction effect between lifetime psychosis and affective lability on social functioning. However, visual inspections of a scatterplot of the relationship between SFS and ALS-SF split by the dichotomous psychosis lifetime variable (Fig. 1) did not indicate an interaction between ALS-SF and psychosis lifetime on social functioning. Thus, we did not include such an interaction term in the regression analysis. As there could be differences between the diagnostic groups in terms of social functioning and to further disentangle putative relationships, follow-up analyses were also carried out in diagnostic subgroups according to current diagnostic nomenclature: schizophrenia spectrum (schizophrenia, schizophreniform, schizoaffective, psychosis NOS; n = 123) and bipolar spectrum (BDI and BDII; n = 170). Here, separate bivariate analyses for the two groups were performed to investigate the association between social functioning and affective lability, in addition to the other relevant demographic and clinical variables. The variables that were significantly associated with the SFS interpersonal score in bivariate analyses for each group were then entered into separate forced entry hierarchical multiple regression models. Due to lower n when the sample was split, the total score of the ALS-SF was used in the multivariate analyses for both groups to ensure enough statistical power when all predictor variables were entered. An interaction term between affective lability and diagnostic subgroup on social functioning was not included as a scatterplot did not indicate the presence of such an interaction (Fig. 2).
All statistical analyses were performed using the Statistical Package for the Social Sciences (SPSS Inc., Chicago, IL, version 26) and a significance level of p ≤ 0.05 (two-tailed tests) was employed.

Results

Demographics and clinical characteristics of the sample

Demographic and clinical characteristics of the sample are presented in Table 1. There were 82 participants without lifetime psychosis; 25/102 (24.5%) in BDI and 57/68 (83.8%) in BDII.
Table 1
Demographics and clinical characteristics
 
Total sample, n = 293
Schizophrenia-spectrum, n = 123
Bipolar-spectrum, n = 170
Statistics
p value
Mean (SD)
Mean (SD)
Mean (SD)
Age (years)
30.1 (9.9)
29.7 (8.9)
31 (10.5)
t = − 1.092, df = 284
0.276
Female sex, n (%)
157 (53.0)
53 (43.1)
101 (59.4)
X2 = 7.625, df = 2
0.006
BD > SZ
SFS interpersonal
223.4 (25.9)
217.1 (27.4)
227.9 (24.1)
t = − 3.586, df = 291
0.000
BD > SZ
Duration of illness, yearsa
8.6 (9.0)
4.9 (6.6)
11.2 (9.5)
t = − 6.675,
df = 288
0.000
BD > SZ
IQ (WASI)b
108 (13.4)
104 (14.8)
110.9 (11.5)
t = − 4.277,
df = 204
0.000
BD > SZ
Total number of illness episodes
9.4 (16.2)
3.9 (4.8)
13.4 (19.9)
t = − 5.981,
df = 196
0.000
BD > SZ
Onset of illness ≤ 18 years, n (%)
123 (42.0)
25 (20.3)
98 (57.6)
X2 = 40.813,
df = 1
0.000
BD > SZ
Duration of untreated illness, weeksc
47 (145.3)
75 (173.3)
22 (109.5)
t = 2.764,
df = 226
0.008
SZ > BD
Premorbid social functioning (PAS)d
1.9 (2.3)
2.1 (2.4)
1.8 (2.3)
t = 1.196,
df = 286
0.233
Psychosis lifetime, n (%)
214 (72.1)
123 (100)
88 (52)
X2 = 82.386,
df = 1
0.000
SZ > BD
PANSS—total
47.8 (13.3)
55.4 (15.1)
42.3 (8.3)
t = 8.702,
df = 175
0.000
SZ > BD
PANSS—Positive
10.4 (3.9)
12.6 (4.4)
8.9 (2.5)
t = 8.488,
df = 178
0.000
SZ > BD
PANSS—Negative
11.2 (4.8)
14.0 (5.7)
9.2 (2.5)
t = 8.797,
df = 157
0.000
SZ > BD
Depression (PANSS item G6)
2.4 (1.3)
2.3 (1.2)
2.5 (1.4)
t = − 1.448,
df = 291
0.149
Anxiety (PANSS item G2)
2.8 (1.3)
2.7 (1.2)
3.1 (1.4)
t = − 1.688,
df = 291
0.092
YMRS—totale
2.6 (3.6)
2.7 (3.6)
2.5 (4.1)
t = .490,
df = 288
0.624
AUDITf
6.8 (6.0)
5.2 (4.9)
8.1 (6.5)
t = − 4.116,
df = 282
0.000
BD > SZ
DUDITg
3.2 (6.6)
3.2 (7.1)
3.2 (6.4)
t = − .068,
df = 281
0.946
ALS-SF—total
1.2 (0.71)
1.1 (0.65)
1.3 (0.73)
t = − 1.890,
df = 291
0.060
ALS-SF anxiety-depression
1.4 (0.87)
1.3 (0.83)
1.5 (0.90)
t = − 1.168,
df = 291
0.244
ALS-SF depression-elation
1.4 (0.74)
1.3 (0.71)
1.4 (0.76)
t = − 1.453,
df = 291
0.147
ALS-SF anger
0.80 (0.78)
0.67 (0.75)
0.90 (0.80)
t = − 2.559,
df = 291
0.011
SFS Social Functioning Scale, WASI Wechsler Abbreviated Scale of Intelligence, PAS Premorbid Adjustment Scale, PANSS Positive and Negative Syndrome Scale, YMRS Young Mania Rating Scale, AUDIT The Alcohol Use Disorders Identification Test, DUDIT Drug Use Disorders Identification Test, ALS-SF Affective Lability Scale Short Form
Statistically significant p values are in bold
a99% (n = 290) participants had data on duration of illness
b93% (n = 273) participants had data on IQ
c78% (n = 228) had data on duration of untreated illness
d98.2% (n = 288) participants had data on PAS
e99% (n = 290) participants had data on YMRS
f96.9% (n = 284) participants had data on AUDIT
g96.6% (n = 283) participants had data on DUDIT

Bivariate analyses in the total sample

Overall, although correlation coefficients are low to moderate, the analyses revealed significant associations between all of the ALS-SF subdimension scores and the SFS interpersonal score (anxiety-depression p < 0.001, depression-elation p = 0.003, anger p < 0.001), as well as the total score (p < 0.001). The SFS interpersonal score was further significantly associated with current manic symptoms, current positive and negative psychotic symptoms, current anxiety and depressive symptoms, duration of untreated illness, total number of illness episodes, as well as premorbid social functioning in childhood (see Table 2 for correlation coefficients). The SFS interpersonal score was not associated with sex, age, illness onset at or before 18, duration of illness, IQ, alcohol- or drug misuse, or the psychosis lifetime variable.
Table 2
Bivariate correlation analyses
 
Total sample
Schizophrenia-spectrum
Bipolar-spectrum
SFS interpersonal
SFS interpersonal
SFS interpersonal
Sex
rs = 0.032
rs = 0.152
rs = − 0.126
Age
rs = 0.020
rs = − 0.031
rs = − 0.016
IQ
r = 0.117
r = − 0.003
r = 0.133
PANSS P
rs = − 0.391**
rs = − 0.426**
rs = − 0.203**
PANSS N
rs = − 0.399**
rs = − 0.470**
rs = − 0.236**
PANSS G2
rs = − 0.236**
rs = − 0.295**
rs = − 0.236**
PANSS G6
rs = − 0.174**
rs = − 0.212*
rs = − 0.208**
YMRS
rs = − 0.142**
rs = − 0.161
rs = − 0.111
AUDIT
r = 0.092
r = 0.103
r = 0.011
DUDIT
rs = − 0.041
rs = − 0.013
rs = 0.019
Psychosis lifetime
rs = − 0.052
n0.a
rs = 0.092
Premorbid social functioning
rs = − 0.218**
rs = − 0.308**
rs = − 0.125
Duration of untreated illness
rs = − 0.197**
rs = − 0.229*
rs = − 0.051
Total number of illness episodes
rs = 0.175**
rs = 0.098
rs = 0.046
Duration of illness
rs = 0.034
rs = − 0.076
rs = − 0.035
ALS-SF total
r = − 0.244**
r = − 0.240**
r = − 0.303**
ALS-SF anxiety-depression
r = − 0.283**
r = − 0.308**
r = − 0.304**
ALS-SF depression-elation
r = − 0.171**
r = − 0.103
r = − 0.265**
ALS-SF anger
r = − 0.208**
r = − 0.246**
r = − 0.249**
SFS Social Functional Scale, PANSS P Positive and Negative Syndrome Scale Positive subscale, PANSS N Positive and Negative Syndrome Scale Negative subscale, PANSS G2 Positive and Negative Syndrome Scale anxiety item, PANSS G6 Positive and Negative Syndrome Scale depression item, YMRS Young Mania Rating Scale, AUDIT The Alcohol Use Disorders Identification Test, DUDIT The Drug Use Disorders Identification Test, ALS-SF Affective Lability Scale Short Form, *p < 0.05, **p < 0.01

Results from multivariate analyses in the total sample

After controlling for potential confounders, higher scores on the anxiety-depression dimension of the ALS-SF were significantly and independently associated with lower social functioning (p = 0.019; model F = 8.249, df = 11, p < 0.001). In addition, higher levels of current positive- and negative symptoms and lower premorbid social adjustment were significantly associated with lower social functioning (R2 for the final model = 0.298; PANSS N p < 0.001; PANSS P p = 0.008; PAS-S p = 0.009, see Table 3). The depression-elation and anger dimensions of the ALS-SF were not significantly associated with social functioning after controlling for potential confounders (p = 0.306 and p = 0.627, respectively). The R2 change for the ALS-SF dimensions block was 3.1%, which is a statistically significant contribution (Sig. F change 0.027). The R2 change for the first block with individual characteristics (PAS-S) was 4.2%, the illness course variables block was 1.9%, and the current symptoms block was 20.6%.
Table 3
Multiple linear regression analysis on the relationship between social functioning and affective lability in the total sample
Covariates
Beta
t test
p value
95% CI for B
Lower bound
Upper bound
Premorbid social functioning
− 0.156
− 2.656
0.009
− 3.034
− 0.449
Duration of untreated illness
0.004
0.064
0.949
− 1.057
1.128
Total number of illness episodes
0.034
0.553
0.581
− 0.140
0.249
Anxiety (PANSS G2)
− 0.068
− 0.959
0.339
− 4.101
1.417
Depression (PANSS G6)
− 0.051
− 0.746
0.456
− 3.618
1.631
PANSS P
− 0.211
− 2.685
0.008
− 2.431
− 0.373
PANSS N
− 0.249
− 3.650
0.000
− 2.072
− 0.619
YMRS
0.001
0.016
0.987
− 0.924
0.938
ALS-SF anxiety-depression
− 0.229
− 2.357
0.019
− 12.487
− 1.113
ALS-SF depression-elation
0.091
1.027
0.306
− 2.922
9.274
ALS-SF anger
− 0.039
− 0.486
0.627
− 6.610
3.995
PANSS G2 Positive and Negative Syndrome Scale anxiety item, PANSS G6 Positive and Negative Syndrome Scale depression item, YMRS Young Mania Rating Scale, PANSS P Positive and Negative Syndrome Scale Positive subscale, PANSS N Positive and Negative Syndrome Scale Negative subscale ALS-SF Affective Lability Scale Short Form
Statistically significant p values are in bold

Follow-up bivariate analyses in diagnostic subgroups

Overall, elevated affective lability was significantly and negatively associated with social functioning in both the schizophrenia- and the bipolar spectrum groups (ALS-SF total score p < 0.01, see Table 2). With respect to the ALS-SF subdimensions, the anxiety-depression and the anger dimensions were significantly associated with the SFS in the schizophrenia spectrum group (p = 0.001 and p = 0.006, respectively). The SFS was further significantly associated with current positive and negative psychotic symptoms, current anxiety and depressive symptoms, premorbid social adjustment in childhood and duration of untreated illness in this group. In the bipolar spectrum group, the association between affective lability and social functioning was significant for all subdimensions (p ≤ 0.001). Here, current anxiety and depressive symptoms and positive and negative psychotic symptoms were also significantly associated with the SFS.

Results from follow-up multivariate analyses in diagnostic subgroups

In the schizophrenia spectrum group, lower social functioning was significantly associated with lower premorbid social functioning in childhood and higher levels of current negative symptoms (p < 0.001 and p = 0.001, respectively; model F = 9.281, df = 7, p < 0.001, R2 for the final model = 0.394), in addition to trend level associations for higher levels of current positive psychotic- (p = 0.055) and depressive symptoms (p = 0.053). Affective lability (ALS-SF total score) was no longer significantly associated with social functioning after correcting for the level of positive symptoms (p = 0.685). There was also a statistically significant association between the ALS total score and the level of positive psychotic symptoms. The analysis thus indicated that the effect of the ALS on the SFS score was mediated through positive psychotic symptoms. In the bipolar spectrum group, elevated affective lability was the strongest predictor of reduced social functioning (p = 0.004; model F = 6.432, df = 5, p < 0.001; R2 for the final model = 0.164). In addition, a higher level of current positive psychotic symptoms was also significantly associated with reduced social functioning in the bipolar spectrum group (p = 0.031). Please refer to supplementary information for regression tables for the subgroups.

Discussion

Affective lability and social functioning in the total sample

In the current study, we found that higher scores on the anxiety-depression dimension of the ALS-SF were significantly associated with lower social functioning in severe mental disorders. Albeit accounting for a modest part of the total variance, this association remained at a level of statistical significance even when we controlled for other well-established predictors of social functioning such as premorbid social functioning, duration of untreated illness, and level of current symptoms. We have previously found that affective lability in our sample was characterized by fluctuations between both anxiety-depression and depression-elation across diagnostic groups [22]. However, only fluctuations between anxiety- and depressive symptoms appear to be directly linked to social functioning. As a majority of the sample (58%) consisted of individuals with bipolar disorder, it was somewhat surprising that an association between the depression-elation dimension and social functioning was not found. This might be an indication that internalizing thoughts and behaviors related to negative affectivity are more disrupting to social functioning compared to externalizing problems that may arise as a result of fluctuations in elation.
In line with some previous studies [25, 26], higher levels of current psychotic symptoms (both positive and negative) contributed the most to reduced social functioning in the total sample, highlighting the importance of achieving symptom remission. From an illness course perspective, whether the participants had previous psychotic episodes or not in their lifetime did not appear to influence the level of social functioning. In an earlier study, we found that elevated affective lability was associated with higher levels of positive psychotic symptoms in schizophrenia spectrum disorders, although directionality could not be inferred [21]. Based on the past and current findings, one may, however, speculate that targeting affective lability in treatment might be beneficial for social functioning in psychotic disorders directly but also via reducing positive psychotic symptoms. Interestingly, while affective symptoms (depressive and manic) were associated with social functioning in the bivariate analyses, their statistical significance was not upheld when entered together with affective lability into the multivariate regression model. We tentatively interpret this as support for the claim that affective lability in the anxiety-depression dimension is indeed a “trait-like” illness feature associated with social functioning independent of elevation in symptom levels.

Affective lability and social functioning in diagnostic subgroups

The follow-up analyses in diagnostic subgroups showed that the significant association between affective lability and social functioning was lost in the schizophrenia spectrum group when other predictors of social functioning were entered into the regression model. Further analyses indicated that the effect of affective lability on social functioning was largely mediated through positive psychotic symptoms in the schizophrenia spectrum group. As noted above, we have also previously reported a significant association between elevated affective lability and increased positive psychotic symptoms in schizophrenia spectrum disorders [21]. Since elevated affective lability is considered a more stable trait that may increase the risk for reality distortion, in line with the notion of an affective pathway to psychosis [68], we interpret our findings as mediation. However, the cross-sectional study design does not rule out the possibility that high levels of positive psychotic symptoms are followed by higher affective lability. More studies, preferably using longitudinal designs, are needed to clarify these relationships in schizophrenia spectrum disorders. In the bipolar spectrum group, on the other hand, affective lability remained significantly and independently associated with social functioning even when the other predictors were taken into account. Nonetheless, as our previous study showed that the level of affective lability is significantly different in BDI versus BDII disorders [22], this finding warrants further investigation in larger samples to tease out if the association between affective lability and social functioning is the same irrespective of bipolar subtype.

Putative mechanisms underlying the relationship between affective lability and social functioning

Healthy social relationships are tied to longer, healthier lives and improved psychological well-being [69]. Thus, improving social functioning should be an important treatment goal in all psychiatric disorders. In fact, research indicates that social factors such as social support and social integration are at least as important for mortality as well-established behavioral risk factors such as smoking, obesity, physical inactivity and high blood-pressure [70]. In severe mental disorders, where life expectancy has been found to be substantially decreased compared to the general population, the health-promoting effects of social factors are perhaps particularly crucial [6870]. The results of the current study indicate that elevated affective lability may be an obstacle to harvesting the benefits of social interactions, although the directionality and the exact mechanisms by which this may exert its effects are, thus far, unclear.
Negative affect has been found to predict social functioning across schizophrenia and bipolar disorder, and high levels of negative affect have been linked to greater fluctuations in affective states [10, 71]. This has again been associated with delayed return to a more adaptive affective baseline which can result in adverse health effects [7274]. One can speculate that a pattern with elevated affective lability, high levels of negative affect and slow return to a neutral physiological state could give rise to a vicious cycle, fostering coping behaviors that are counterproductive to social functioning, such as withdrawal, avoidance and disengagement. Over time, this may interfere with the drive to forge and maintain both peripheral and close social connections [7578], which is deleterious to well-being and longevity [79, 80]. Feeding into this potential negative cycle, social settings are in themselves triggering to a host of different affective experiences due to their ever-changing, ambiguous and unpredictable nature. Successful social navigation is therefore contingent upon having a clear representation of one’s own internal affective state to guide appropriate behavior and responses [81]. Elevated affective lability might make it distinctively more difficult to differentiate, categorize and label affective states in a precise and specific way, i.e. result in low emotional granularity [82], which has further been associated with social dysfunction [8386]. Collectively and tentatively, affective lability may contribute to steering individuals away from the social world while features in the social world, in turn, may increase affective lability, generating negative interactions that contribute to impairments in social functioning.

Limitations and strengths

The findings of the present study must be interpreted in light of some limitations. Causal attributions are precluded due to the cross-sectional nature of the study and data on comorbid disorders such as personality disorders, ADHD and anxiety disorders are lacking. In addition, since this is a naturalistic study, the participants have typically received a broad range, as well as different combinations, of pharmacological and psychosocial treatments that would be very difficult to control for in the statistical analyses. Furthermore, as the ALS-SF and the SFS are based on self-report, there is a risk for recall- and response bias that cannot be ruled out. Finally, the measures used for anxiety and depressive symptoms are based on a scale primarily developed for assessing psychotic symptoms. Hence, the possibility that current symptoms still could have influenced the association between affective lability and social functioning cannot be ruled out completely. However, we believe that the likelihood of this is limited due to the relatively low levels of anxiety and depressive symptoms. The study also has several strengths; it demonstrates that there are associations between affective lability and social functioning in a large, diagnostically well-characterized sample of participants with severe mental disorders while accounting for many other well-documented confounding variables. To our knowledge, this has not been shown previously.

Conclusions

Our results indicate that elevated affective lability may have a negative impact on social functioning in severe mental disorders. If replicated, this could have important clinical implications as affective lability can be targeted in treatment through various forms of emotion regulation skills training. Future research should address whether a therapeutic focus on affective lability could be one pathway towards improving social outcomes in severe mental disorders.

Acknowledgements

The authors would like to extend a sincere thank you to all the participants in the TOP study for their time and effort. We would also like to thank everyone at NORMENT.

Declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical approval

The TOP study is conducted in line with the Helsinki declaration of 1975 (as revised in 2008 and 2013) and has been approved by the Regional Committee for Medical Research Ethics and the Norwegian Data Inspectorate.
All participants must be able to provide informed consent before entering the study.
Not applicable.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
2.
Zurück zum Zitat Brissos S, Balanza-Martinez V, Dias VV, Carita AI, Figueira ML (2011) Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community? Eur Arch Psychiatry Clin Neurosci 261(7):509–517PubMedCrossRef Brissos S, Balanza-Martinez V, Dias VV, Carita AI, Figueira ML (2011) Is personal and social functioning associated with subjective quality of life in schizophrenia patients living in the community? Eur Arch Psychiatry Clin Neurosci 261(7):509–517PubMedCrossRef
3.
Zurück zum Zitat Bjornestad J, Hegelstad WTV, Berg H, Davidson L, Joa I, Johannessen JO et al (2019) Social media and social functioning in psychosis: a systematic review. J Med Internet Res 21(6):e13957PubMedPubMedCentralCrossRef Bjornestad J, Hegelstad WTV, Berg H, Davidson L, Joa I, Johannessen JO et al (2019) Social media and social functioning in psychosis: a systematic review. J Med Internet Res 21(6):e13957PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Bennett F, Hodgetts S, Close A, Frye M, Grunze H, Keck P et al (2019) Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar Network. Int J Bipolar Disord 7(1):28PubMedPubMedCentralCrossRef Bennett F, Hodgetts S, Close A, Frye M, Grunze H, Keck P et al (2019) Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar Network. Int J Bipolar Disord 7(1):28PubMedPubMedCentralCrossRef
5.
Zurück zum Zitat Jazaieri H, Urry HL, Gross JJ (2013) Affective disturbance and psychopathology: An emotion regulation perspective. J Exp Psychopathol 4(5):584–599CrossRef Jazaieri H, Urry HL, Gross JJ (2013) Affective disturbance and psychopathology: An emotion regulation perspective. J Exp Psychopathol 4(5):584–599CrossRef
6.
Zurück zum Zitat Moritz S, Berna F, Jaeger S, Westermann S, Nagel M (2017) The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis. Eur Arch Psychiatry Clin Neurosci 267(4):335–339PubMedCrossRef Moritz S, Berna F, Jaeger S, Westermann S, Nagel M (2017) The customer is always right? Subjective target symptoms and treatment preferences in patients with psychosis. Eur Arch Psychiatry Clin Neurosci 267(4):335–339PubMedCrossRef
7.
Zurück zum Zitat Kuhnigk O, Slawik L, Meyer J, Naber D, Reimer J (2012) Valuation and attainment of treatment goals in schizophrenia: perspectives of patients, relatives, physicians, and payers. J Psychiatr Pract 18(5):321–328PubMedCrossRef Kuhnigk O, Slawik L, Meyer J, Naber D, Reimer J (2012) Valuation and attainment of treatment goals in schizophrenia: perspectives of patients, relatives, physicians, and payers. J Psychiatr Pract 18(5):321–328PubMedCrossRef
8.
Zurück zum Zitat Law H, Shryane N, Bentall RP, Morrison AP (2016) Longitudinal predictors of subjective recovery in psychosis. Br J Psychiatry 209(1):48–53PubMedCrossRef Law H, Shryane N, Bentall RP, Morrison AP (2016) Longitudinal predictors of subjective recovery in psychosis. Br J Psychiatry 209(1):48–53PubMedCrossRef
9.
Zurück zum Zitat Tso IF, Grove TB, Taylor SF (2010) Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia. Schizophr Res 122(1–3):156–163PubMedPubMedCentralCrossRef Tso IF, Grove TB, Taylor SF (2010) Emotional experience predicts social adjustment independent of neurocognition and social cognition in schizophrenia. Schizophr Res 122(1–3):156–163PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Grove TB, Tso IF, Chun J, Mueller SA, Taylor SF, Ellingrod VL et al (2016) Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis. Psychiatry Res 243:198–206PubMedPubMedCentralCrossRef Grove TB, Tso IF, Chun J, Mueller SA, Taylor SF, Ellingrod VL et al (2016) Negative affect predicts social functioning across schizophrenia and bipolar disorder: Findings from an integrated data analysis. Psychiatry Res 243:198–206PubMedPubMedCentralCrossRef
11.
12.
Zurück zum Zitat Gershon A, Eidelman P (2015) Inter-episode affective intensity and instability: predictors of depression and functional impairment in bipolar disorder. J Behav Ther Exp Psychiatry 46:14–18PubMedCrossRef Gershon A, Eidelman P (2015) Inter-episode affective intensity and instability: predictors of depression and functional impairment in bipolar disorder. J Behav Ther Exp Psychiatry 46:14–18PubMedCrossRef
13.
Zurück zum Zitat Bonnin CM, Sanchez-Moreno J, Martinez-Aran A, Sole B, Reinares M, Rosa AR et al (2012) Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord 136(3):650–659PubMedCrossRef Bonnin CM, Sanchez-Moreno J, Martinez-Aran A, Sole B, Reinares M, Rosa AR et al (2012) Subthreshold symptoms in bipolar disorder: impact on neurocognition, quality of life and disability. J Affect Disord 136(3):650–659PubMedCrossRef
14.
Zurück zum Zitat Stanislaus S, Faurholt-Jepsen M, Vinberg M, Coello K, Kjaerstad HL, Melbye S et al (2020) Mood instability in patients with newly diagnosed bipolar disorder, unaffected relatives, and healthy control individuals measured daily using smartphones. J Affect Disord 271:336–344PubMedCrossRef Stanislaus S, Faurholt-Jepsen M, Vinberg M, Coello K, Kjaerstad HL, Melbye S et al (2020) Mood instability in patients with newly diagnosed bipolar disorder, unaffected relatives, and healthy control individuals measured daily using smartphones. J Affect Disord 271:336–344PubMedCrossRef
15.
Zurück zum Zitat Vodusek VV, Parnas J, Tomori M, Skodlar B (2014) The phenomenology of emotion experience in first-episode psychosis. Psychopathology 47(4):252–260PubMedCrossRef Vodusek VV, Parnas J, Tomori M, Skodlar B (2014) The phenomenology of emotion experience in first-episode psychosis. Psychopathology 47(4):252–260PubMedCrossRef
16.
Zurück zum Zitat Hofmann SG, Doan SN (2018) The social foundations of emotion : developmental, cultural, and clinical dimensions, 1st edn. American Psychological Association, WashingtonCrossRef Hofmann SG, Doan SN (2018) The social foundations of emotion : developmental, cultural, and clinical dimensions, 1st edn. American Psychological Association, WashingtonCrossRef
17.
Zurück zum Zitat Van Rheenen TE, Rossell SL (2014) Phenomenological predictors of psychosocial function in bipolar disorder: is there evidence that social cognitive and emotion regulation abnormalities contribute? Aust N Z J Psychiatry 48(1):26–35PubMedCrossRef Van Rheenen TE, Rossell SL (2014) Phenomenological predictors of psychosocial function in bipolar disorder: is there evidence that social cognitive and emotion regulation abnormalities contribute? Aust N Z J Psychiatry 48(1):26–35PubMedCrossRef
18.
Zurück zum Zitat Van Rheenen TE, Rossell SL (2014) Objective and subjective psychosocial functioning in bipolar disorder: an investigation of the relative importance of neurocognition, social cognition and emotion regulation. J Affect Disord 162:134–141PubMedCrossRef Van Rheenen TE, Rossell SL (2014) Objective and subjective psychosocial functioning in bipolar disorder: an investigation of the relative importance of neurocognition, social cognition and emotion regulation. J Affect Disord 162:134–141PubMedCrossRef
19.
Zurück zum Zitat Marwaha S, He Z, Broome M, Singh SP, Scott J, Eyden J et al (2014) How is affective instability defined and measured? A systematic review. Psychol Med 44(9):1793–1808PubMedCrossRef Marwaha S, He Z, Broome M, Singh SP, Scott J, Eyden J et al (2014) How is affective instability defined and measured? A systematic review. Psychol Med 44(9):1793–1808PubMedCrossRef
21.
Zurück zum Zitat Høegh MC, Melle I, Aminoff SR, Laskemoen JF, Büchmann CB, Ueland T et al (2020) Affective lability across psychosis spectrum disorders. Eur Psychiatry 63(1):e53PubMedPubMedCentralCrossRef Høegh MC, Melle I, Aminoff SR, Laskemoen JF, Büchmann CB, Ueland T et al (2020) Affective lability across psychosis spectrum disorders. Eur Psychiatry 63(1):e53PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Høegh MC, Melle I, Aminoff SR, Haatveit B, Olsen SH, Huflåtten IB et al (2021) Characterization of affective lability across subgroups of psychosis spectrum disorders. Int J Bipolar Disord 9(1):34PubMedPubMedCentralCrossRef Høegh MC, Melle I, Aminoff SR, Haatveit B, Olsen SH, Huflåtten IB et al (2021) Characterization of affective lability across subgroups of psychosis spectrum disorders. Int J Bipolar Disord 9(1):34PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Bottlender R, Strauss A, Moller HJ (2010) Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission. Schizophr Res 116(1):9–15PubMedCrossRef Bottlender R, Strauss A, Moller HJ (2010) Social disability in schizophrenic, schizoaffective and affective disorders 15 years after first admission. Schizophr Res 116(1):9–15PubMedCrossRef
24.
Zurück zum Zitat Simonsen C, Sundet K, Vaskinn A, Ueland T, Romm KL, Hellvin T et al (2010) Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms. J Int Neuropsychol Soc 16(5):771–783PubMedCrossRef Simonsen C, Sundet K, Vaskinn A, Ueland T, Romm KL, Hellvin T et al (2010) Psychosocial function in schizophrenia and bipolar disorder: Relationship to neurocognition and clinical symptoms. J Int Neuropsychol Soc 16(5):771–783PubMedCrossRef
26.
Zurück zum Zitat Bowie CR, Best MW, Depp C, Mausbach BT, Patterson TL, Pulver AE et al (2018) Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis. Bipolar Disord 20(7):604–613PubMedCrossRef Bowie CR, Best MW, Depp C, Mausbach BT, Patterson TL, Pulver AE et al (2018) Cognitive and functional deficits in bipolar disorder and schizophrenia as a function of the presence and history of psychosis. Bipolar Disord 20(7):604–613PubMedCrossRef
27.
Zurück zum Zitat Levy B, Medina AM, Weiss RD (2013) Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal study. Compr Psychiatry 54(6):618–626PubMedPubMedCentralCrossRef Levy B, Medina AM, Weiss RD (2013) Cognitive and psychosocial functioning in bipolar disorder with and without psychosis during early remission from an acute mood episode: a comparative longitudinal study. Compr Psychiatry 54(6):618–626PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Morriss R, Yang M, Chopra A, Bentall R, Paykel E, Scott J (2013) Differential effects of depression and mania symptoms on social adjustment: prospective study in bipolar disorder. Bipolar Disord 15(1):80–91PubMedCrossRef Morriss R, Yang M, Chopra A, Bentall R, Paykel E, Scott J (2013) Differential effects of depression and mania symptoms on social adjustment: prospective study in bipolar disorder. Bipolar Disord 15(1):80–91PubMedCrossRef
29.
Zurück zum Zitat Goldberg JF, Harrow M (2011) A 15-year prospective follow-up of bipolar affective disorders: comparisons with unipolar nonpsychotic depression. Bipolar Disord 13(2):155–163PubMedCrossRef Goldberg JF, Harrow M (2011) A 15-year prospective follow-up of bipolar affective disorders: comparisons with unipolar nonpsychotic depression. Bipolar Disord 13(2):155–163PubMedCrossRef
30.
Zurück zum Zitat Conley RR (2009) The burden of depressive symptoms in people with schizophrenia. Psychiatr Clin North Am 32(4):853–861PubMedCrossRef Conley RR (2009) The burden of depressive symptoms in people with schizophrenia. Psychiatr Clin North Am 32(4):853–861PubMedCrossRef
31.
Zurück zum Zitat Upthegrove R, Marwaha S, Birchwood M (2017) Depression and schizophrenia: cause, consequence, or trans-diagnostic issue? Schizophr Bull 43(2):240–244PubMed Upthegrove R, Marwaha S, Birchwood M (2017) Depression and schizophrenia: cause, consequence, or trans-diagnostic issue? Schizophr Bull 43(2):240–244PubMed
32.
Zurück zum Zitat van Rooijen G, van Rooijen M, Maat A, Vermeulen JM, Meijer CJ, Ruhe HG et al (2019) Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling. Schizophr Res 208:82–89PubMedCrossRef van Rooijen G, van Rooijen M, Maat A, Vermeulen JM, Meijer CJ, Ruhe HG et al (2019) Longitudinal evidence for a relation between depressive symptoms and quality of life in schizophrenia using structural equation modeling. Schizophr Res 208:82–89PubMedCrossRef
33.
34.
Zurück zum Zitat Morriss R, Scott J, Paykel E, Bentall R, Hayhurst H, Johnson T (2007) Social adjustment based on reported behaviour in bipolar affective disorder. Bipolar Disord 9(1–2):53–62PubMedCrossRef Morriss R, Scott J, Paykel E, Bentall R, Hayhurst H, Johnson T (2007) Social adjustment based on reported behaviour in bipolar affective disorder. Bipolar Disord 9(1–2):53–62PubMedCrossRef
35.
Zurück zum Zitat Grossman LS, Harrow M, Rosen C, Faull R (2006) Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatr Serv 57(6):844–850PubMedCrossRef Grossman LS, Harrow M, Rosen C, Faull R (2006) Sex differences in outcome and recovery for schizophrenia and other psychotic and nonpsychotic disorders. Psychiatr Serv 57(6):844–850PubMedCrossRef
36.
Zurück zum Zitat Velthorst E, Fett AJ, Reichenberg A, Perlman G, van Os J, Bromet EJ et al (2017) The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders. Am J Psychiatry 174(11):1075–1085PubMedCrossRef Velthorst E, Fett AJ, Reichenberg A, Perlman G, van Os J, Bromet EJ et al (2017) The 20-Year Longitudinal Trajectories of Social Functioning in Individuals With Psychotic Disorders. Am J Psychiatry 174(11):1075–1085PubMedCrossRef
37.
Zurück zum Zitat Ratheesh A, Davey CG, Daglas R, Macneil C, Hasty M, Filia K et al (2017) Social and academic premorbid adjustment domains predict different functional outcomes among youth with first episode mania. J Affect Disord 219:133–140PubMedCrossRef Ratheesh A, Davey CG, Daglas R, Macneil C, Hasty M, Filia K et al (2017) Social and academic premorbid adjustment domains predict different functional outcomes among youth with first episode mania. J Affect Disord 219:133–140PubMedCrossRef
38.
Zurück zum Zitat Sanchez-Moreno J, Martinez-Aran A, Tabares-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL (2009) Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom 78(5):285–297PubMedCrossRef Sanchez-Moreno J, Martinez-Aran A, Tabares-Seisdedos R, Torrent C, Vieta E, Ayuso-Mateos JL (2009) Functioning and disability in bipolar disorder: an extensive review. Psychother Psychosom 78(5):285–297PubMedCrossRef
39.
Zurück zum Zitat Rymaszewska J, Mazurek J (2012) The social and occupational functioning of outpatients from mental health services. Adv Clin Exp Med 21(2):215–223PubMed Rymaszewska J, Mazurek J (2012) The social and occupational functioning of outpatients from mental health services. Adv Clin Exp Med 21(2):215–223PubMed
40.
Zurück zum Zitat Penttila M, Jaaskelainen E, Hirvonen N, Isohanni M, Miettunen J (2014) Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 205(2):88–94PubMedCrossRef Penttila M, Jaaskelainen E, Hirvonen N, Isohanni M, Miettunen J (2014) Duration of untreated psychosis as predictor of long-term outcome in schizophrenia: systematic review and meta-analysis. Br J Psychiatry 205(2):88–94PubMedCrossRef
41.
Zurück zum Zitat Joyce K, Thompson A, Marwaha S (2016) Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature review. Int J Bipolar Disord 4(1):19PubMedPubMedCentralCrossRef Joyce K, Thompson A, Marwaha S (2016) Is treatment for bipolar disorder more effective earlier in illness course? A comprehensive literature review. Int J Bipolar Disord 4(1):19PubMedPubMedCentralCrossRef
42.
Zurück zum Zitat Gade K, Malzahn D, Anderson-Schmidt H, Strohmaier J, Meier S, Frank J et al (2015) Functional outcome in major psychiatric disorders and associated clinical and psychosocial variables: A potential cross-diagnostic phenotype for further genetic investigations? World J Biol Psychiatry 16(4):237–248PubMedCrossRef Gade K, Malzahn D, Anderson-Schmidt H, Strohmaier J, Meier S, Frank J et al (2015) Functional outcome in major psychiatric disorders and associated clinical and psychosocial variables: A potential cross-diagnostic phenotype for further genetic investigations? World J Biol Psychiatry 16(4):237–248PubMedCrossRef
43.
Zurück zum Zitat Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW et al (2010) The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 36(1):48–70PubMedCrossRef Dixon LB, Dickerson F, Bellack AS, Bennett M, Dickinson D, Goldberg RW et al (2010) The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements. Schizophr Bull 36(1):48–70PubMedCrossRef
44.
Zurück zum Zitat Hower H, Lee EJ, Jones RN, Birmaher B, Strober M, Goldstein BI et al (2019) Predictors of longitudinal psychosocial functioning in bipolar youth transitioning to adults. J Affect Disord 246:578–585PubMedCrossRef Hower H, Lee EJ, Jones RN, Birmaher B, Strober M, Goldstein BI et al (2019) Predictors of longitudinal psychosocial functioning in bipolar youth transitioning to adults. J Affect Disord 246:578–585PubMedCrossRef
45.
Zurück zum Zitat Spoorthy MS, Chakrabarti S, Grover S (2019) Comorbidity of bipolar and anxiety disorders: an overview of trends in research. World J Psychiatry 9(1):7–29PubMedPubMedCentralCrossRef Spoorthy MS, Chakrabarti S, Grover S (2019) Comorbidity of bipolar and anxiety disorders: an overview of trends in research. World J Psychiatry 9(1):7–29PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat Faurholt-Jepsen M, Frost M, Christensen EM, Bardram JE, Vinberg M, Kessing LV (2019) The validity of daily patient-reported anxiety measured using smartphones and the association with stress, quality of life and functioning in patients with bipolar disorder. J Affect Disord 257:100–107PubMedCrossRef Faurholt-Jepsen M, Frost M, Christensen EM, Bardram JE, Vinberg M, Kessing LV (2019) The validity of daily patient-reported anxiety measured using smartphones and the association with stress, quality of life and functioning in patients with bipolar disorder. J Affect Disord 257:100–107PubMedCrossRef
47.
Zurück zum Zitat First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV axis I disorders: patient edition (SCID-P), version 21995 First MB, Spitzer RL, Gibbon M, Williams JBW (1995) Structured clinical interview for DSM-IV axis I disorders: patient edition (SCID-P), version 21995
48.
Zurück zum Zitat Ventura J, Liberman RP, Green MF, Shaner A, Mintz J (1998) Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res 79(2):163–173PubMedCrossRef Ventura J, Liberman RP, Green MF, Shaner A, Mintz J (1998) Training and quality assurance with the Structured Clinical Interview for DSM-IV (SCID-I/P). Psychiatry Res 79(2):163–173PubMedCrossRef
49.
Zurück zum Zitat Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S (1990) The Social Functioning Scale The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 157:853–859PubMedCrossRef Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S (1990) The Social Functioning Scale The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 157:853–859PubMedCrossRef
50.
Zurück zum Zitat Hellvin T, Sundet K, Vaskinn A, Simonsen C, Ueland T, Andreassen OA et al (2010) Validation of the Norwegian version of the Social Functioning Scale (SFS) for schizophrenia and bipolar disorder. Scand J Psychol 51(6):525–533PubMedCrossRef Hellvin T, Sundet K, Vaskinn A, Simonsen C, Ueland T, Andreassen OA et al (2010) Validation of the Norwegian version of the Social Functioning Scale (SFS) for schizophrenia and bipolar disorder. Scand J Psychol 51(6):525–533PubMedCrossRef
51.
Zurück zum Zitat Chan EHC, Kong SDX, Park SH, Song YJC, Demetriou EA, Pepper KL et al (2019) Validation of the social functioning scale: Comparison and evaluation in early psychosis, autism spectrum disorder and social anxiety disorder. Psychiatry Res 276:45–55PubMedCrossRef Chan EHC, Kong SDX, Park SH, Song YJC, Demetriou EA, Pepper KL et al (2019) Validation of the social functioning scale: Comparison and evaluation in early psychosis, autism spectrum disorder and social anxiety disorder. Psychiatry Res 276:45–55PubMedCrossRef
52.
Zurück zum Zitat Vazquez Morejon AJ, Jimenez G-B (2000) Social functioning scale: new contributions concerning its psychometric characteristics in a Spanish adaptation. Psychiatry Res 93(3):247–256PubMedCrossRef Vazquez Morejon AJ, Jimenez G-B (2000) Social functioning scale: new contributions concerning its psychometric characteristics in a Spanish adaptation. Psychiatry Res 93(3):247–256PubMedCrossRef
53.
Zurück zum Zitat Iffland JR, Lockhofen D, Gruppe H, Gallhofer B, Sammer G, Hanewald B (2015) Validation of the German Version of the Social Functioning Scale (SFS) for schizophrenia. PLoS ONE 10(4):e0121807PubMedPubMedCentralCrossRef Iffland JR, Lockhofen D, Gruppe H, Gallhofer B, Sammer G, Hanewald B (2015) Validation of the German Version of the Social Functioning Scale (SFS) for schizophrenia. PLoS ONE 10(4):e0121807PubMedPubMedCentralCrossRef
54.
Zurück zum Zitat Schneider M, Reininghaus U, van Nierop M, Janssens M, Myin-Germeys I, Investigators G (2017) Does the Social Functioning Scale reflect real-life social functioning? An experience sampling study in patients with a non-affective psychotic disorder and healthy control individuals. Psychol Med 47(16):2777–2786PubMedCrossRef Schneider M, Reininghaus U, van Nierop M, Janssens M, Myin-Germeys I, Investigators G (2017) Does the Social Functioning Scale reflect real-life social functioning? An experience sampling study in patients with a non-affective psychotic disorder and healthy control individuals. Psychol Med 47(16):2777–2786PubMedCrossRef
55.
Zurück zum Zitat Oliver MNI, Simons JS (2004) The affective lability scales: development of a short-form measure. Pers Indiv Differ 37(6):1279–1288CrossRef Oliver MNI, Simons JS (2004) The affective lability scales: development of a short-form measure. Pers Indiv Differ 37(6):1279–1288CrossRef
56.
Zurück zum Zitat Aas M, Pedersen G, Henry C, Bjella T, Bellivier F, Leboyer M et al (2015) Psychometric properties of the Affective Lability Scale (54 and 18-item version) in patients with bipolar disorder, first-degree relatives, and healthy controls. J Affect Disord 172:375–380PubMedCrossRef Aas M, Pedersen G, Henry C, Bjella T, Bellivier F, Leboyer M et al (2015) Psychometric properties of the Affective Lability Scale (54 and 18-item version) in patients with bipolar disorder, first-degree relatives, and healthy controls. J Affect Disord 172:375–380PubMedCrossRef
57.
Zurück zum Zitat Look AE, Flory JD, Harvey PD, Siever LJ (2010) Psychometric properties of a short form of the Affective Lability Scale (ALS-18). Pers Individ Dif 49(3):187–191PubMedPubMedCentralCrossRef Look AE, Flory JD, Harvey PD, Siever LJ (2010) Psychometric properties of a short form of the Affective Lability Scale (ALS-18). Pers Individ Dif 49(3):187–191PubMedPubMedCentralCrossRef
58.
Zurück zum Zitat Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8(3):470–484PubMedCrossRef Cannon-Spoor HE, Potkin SG, Wyatt RJ (1982) Measurement of premorbid adjustment in chronic schizophrenia. Schizophr Bull 8(3):470–484PubMedCrossRef
59.
Zurück zum Zitat van Mastrigt S, Addington J (2002) Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci 27(2):92–101PubMedPubMedCentral van Mastrigt S, Addington J (2002) Assessment of premorbid function in first-episode schizophrenia: modifications to the Premorbid Adjustment Scale. J Psychiatry Neurosci 27(2):92–101PubMedPubMedCentral
60.
Zurück zum Zitat Wechsler D (2007) Wechsler Abbreviated Scale of Intelligence. Norwegian Manual Supplement. Pearson Assessment, Stockholm Wechsler D (2007) Wechsler Abbreviated Scale of Intelligence. Norwegian Manual Supplement. Pearson Assessment, Stockholm
61.
Zurück zum Zitat Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276PubMedCrossRef Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276PubMedCrossRef
62.
Zurück zum Zitat Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435PubMedCrossRef Young RC, Biggs JT, Ziegler VE, Meyer DA (1978) A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 133:429–435PubMedCrossRef
63.
Zurück zum Zitat Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction 88(6):791–804PubMedCrossRef Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M (1993) Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption–II. Addiction 88(6):791–804PubMedCrossRef
64.
Zurück zum Zitat Berman AH, Bergman H, Palmstierna T, Schlyter F (2005) Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 11(1):22–31PubMedCrossRef Berman AH, Bergman H, Palmstierna T, Schlyter F (2005) Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. Eur Addict Res 11(1):22–31PubMedCrossRef
65.
Zurück zum Zitat Jaworski F, Dubertret C, Ades J, Gorwood P (2011) Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia. Psychiatry Res 185(1–2):129–134PubMedCrossRef Jaworski F, Dubertret C, Ades J, Gorwood P (2011) Presence of co-morbid substance use disorder in bipolar patients worsens their social functioning to the level observed in patients with schizophrenia. Psychiatry Res 185(1–2):129–134PubMedCrossRef
66.
Zurück zum Zitat Bahorik AL, Newhill CE, Eack SM (2013) Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction 108(7):1259–1269PubMedPubMedCentralCrossRef Bahorik AL, Newhill CE, Eack SM (2013) Characterizing the longitudinal patterns of substance use among individuals diagnosed with serious mental illness after psychiatric hospitalization. Addiction 108(7):1259–1269PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Myin-Germeys I, van Os J (2007) Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev 27(4):409–424PubMedCrossRef Myin-Germeys I, van Os J (2007) Stress-reactivity in psychosis: evidence for an affective pathway to psychosis. Clin Psychol Rev 27(4):409–424PubMedCrossRef
70.
Zurück zum Zitat Haslam SA, McMahon C, Cruwys T, Haslam C, Jetten J, Steffens NK (2018) Social cure, what social cure? The propensity to underestimate the importance of social factors for health. Soc Sci Med 198:14–21PubMedCrossRef Haslam SA, McMahon C, Cruwys T, Haslam C, Jetten J, Steffens NK (2018) Social cure, what social cure? The propensity to underestimate the importance of social factors for health. Soc Sci Med 198:14–21PubMedCrossRef
71.
Zurück zum Zitat Johnson SL, Tharp JA, Peckham AD, McMaster KJ (2016) Emotion in bipolar I disorder: Implications for functional and symptom outcomes. J Abnorm Psychol 125(1):40–52PubMedCrossRef Johnson SL, Tharp JA, Peckham AD, McMaster KJ (2016) Emotion in bipolar I disorder: Implications for functional and symptom outcomes. J Abnorm Psychol 125(1):40–52PubMedCrossRef
72.
Zurück zum Zitat Koenigsberg HW (2010) Affective instability: toward an integration of neuroscience and psychological perspectives. J Pers Disord 24(1):60–82PubMedCrossRef Koenigsberg HW (2010) Affective instability: toward an integration of neuroscience and psychological perspectives. J Pers Disord 24(1):60–82PubMedCrossRef
73.
Zurück zum Zitat Dargel AA, Volant S, Brietzke E, Etain B, Olie E, Azorin JM et al (2020) Allostatic load, emotional hyper-reactivity, and functioning in individuals with bipolar disorder. Bipolar Disord 22(7):711–721PubMedCrossRef Dargel AA, Volant S, Brietzke E, Etain B, Olie E, Azorin JM et al (2020) Allostatic load, emotional hyper-reactivity, and functioning in individuals with bipolar disorder. Bipolar Disord 22(7):711–721PubMedCrossRef
74.
Zurück zum Zitat Dargel AA, Volant S, Saha S, Etain B, Grant R, Azorin JM et al (2019) Activation Levels, cardiovascular risk, and functional impairment in remitted bipolar patients: clinical relevance of a dimensional approach. Psychother Psychosom 88(1):45–47PubMedCrossRef Dargel AA, Volant S, Saha S, Etain B, Grant R, Azorin JM et al (2019) Activation Levels, cardiovascular risk, and functional impairment in remitted bipolar patients: clinical relevance of a dimensional approach. Psychother Psychosom 88(1):45–47PubMedCrossRef
75.
Zurück zum Zitat Brent LJ, Chang SW, Gariepy JF, Platt ML (2014) The neuroethology of friendship. Ann N Y Acad Sci 1316:1–17PubMedCrossRef Brent LJ, Chang SW, Gariepy JF, Platt ML (2014) The neuroethology of friendship. Ann N Y Acad Sci 1316:1–17PubMedCrossRef
76.
Zurück zum Zitat Lyubomirsky S, King L, Diener E (2005) The benefits of frequent positive affect: does happiness lead to success? Psychol Bull 131(6):803–855PubMedCrossRef Lyubomirsky S, King L, Diener E (2005) The benefits of frequent positive affect: does happiness lead to success? Psychol Bull 131(6):803–855PubMedCrossRef
77.
Zurück zum Zitat Bjornestad J, Joa I, Larsen TK, Langeveld J, Davidson L, Ten Velden HW et al (2016) “Everyone Needs a Friend Sometimes”—social predictors of long-term remission in first episode psychosis. Front Psychol 7:1491PubMedPubMedCentralCrossRef Bjornestad J, Joa I, Larsen TK, Langeveld J, Davidson L, Ten Velden HW et al (2016) “Everyone Needs a Friend Sometimes”—social predictors of long-term remission in first episode psychosis. Front Psychol 7:1491PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Sandstrom GM, Dunn EW (2014) Social interactions and well-being: the surprising power of weak ties. Pers Soc Psychol Bull 40(7):910–922PubMedCrossRef Sandstrom GM, Dunn EW (2014) Social interactions and well-being: the surprising power of weak ties. Pers Soc Psychol Bull 40(7):910–922PubMedCrossRef
79.
Zurück zum Zitat Yang YC, Boen C, Gerken K, Li T, Schorpp K, Harris KM (2016) Social relationships and physiological determinants of longevity across the human life span. Proc Natl Acad Sci USA 113(3):578–583PubMedPubMedCentralCrossRef Yang YC, Boen C, Gerken K, Li T, Schorpp K, Harris KM (2016) Social relationships and physiological determinants of longevity across the human life span. Proc Natl Acad Sci USA 113(3):578–583PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Slavich GM, Irwin MR (2014) From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 140(3):774–815PubMedPubMedCentralCrossRef Slavich GM, Irwin MR (2014) From stress to inflammation and major depressive disorder: a social signal transduction theory of depression. Psychol Bull 140(3):774–815PubMedPubMedCentralCrossRef
82.
Zurück zum Zitat Erbas Y, Ceulemans E, Blanke ES, Sels L, Fischer A, Kuppens P (2019) Emotion differentiation dissected: between-category, within-category, and integral emotion differentiation, and their relation to well-being. Cogn Emot 33(2):258–271PubMedCrossRef Erbas Y, Ceulemans E, Blanke ES, Sels L, Fischer A, Kuppens P (2019) Emotion differentiation dissected: between-category, within-category, and integral emotion differentiation, and their relation to well-being. Cogn Emot 33(2):258–271PubMedCrossRef
83.
Zurück zum Zitat Kashdan TB, Barrett LF, McKnight PE (2015) Unpacking emotion differentiation: transforming unpleasant experience by perceiving distinctions in negativity. Curr Dir Psychol Sci 24(1):7CrossRef Kashdan TB, Barrett LF, McKnight PE (2015) Unpacking emotion differentiation: transforming unpleasant experience by perceiving distinctions in negativity. Curr Dir Psychol Sci 24(1):7CrossRef
84.
Zurück zum Zitat Kimhy D, Vakhrusheva J, Khan S, Chang RW, Hansen MC, Ballon JS et al (2014) Emotional granularity and social functioning in individuals with schizophrenia: an experience sampling study. J Psychiatr Res 53:141–148PubMedPubMedCentralCrossRef Kimhy D, Vakhrusheva J, Khan S, Chang RW, Hansen MC, Ballon JS et al (2014) Emotional granularity and social functioning in individuals with schizophrenia: an experience sampling study. J Psychiatr Res 53:141–148PubMedPubMedCentralCrossRef
85.
Zurück zum Zitat Dixon-Gordon KL, Chapman AL, Weiss NH, Rosenthal MZ (2014) A preliminary examination of the role of emotion differentiation in the relationship between borderline personality and urges for maladaptive behaviors. J Psychopathol Behav Assess 36(4):616–625PubMedPubMedCentralCrossRef Dixon-Gordon KL, Chapman AL, Weiss NH, Rosenthal MZ (2014) A preliminary examination of the role of emotion differentiation in the relationship between borderline personality and urges for maladaptive behaviors. J Psychopathol Behav Assess 36(4):616–625PubMedPubMedCentralCrossRef
86.
Zurück zum Zitat Suvak MK, Litz BT, Sloan DM, Zanarini MC, Barrett LF, Hofmann SG (2011) Emotional granularity and borderline personality disorder. J Abnorm Psychol 120(2):414–426PubMedPubMedCentralCrossRef Suvak MK, Litz BT, Sloan DM, Zanarini MC, Barrett LF, Hofmann SG (2011) Emotional granularity and borderline personality disorder. J Abnorm Psychol 120(2):414–426PubMedPubMedCentralCrossRef
Metadaten
Titel
Affective lability and social functioning in severe mental disorders
verfasst von
Margrethe Collier Høegh
Ingrid Melle
Sofie R. Aminoff
Stine Holmstul Olsen
Synve Hoffart Lunding
Torill Ueland
Trine Vik Lagerberg
Publikationsdatum
27.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 5/2022
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-022-01380-1

Neu im Fachgebiet Psychiatrie

Einer von sieben Frauen macht die Menopause sehr zu schaffen

Von mäßigen bis schweren vasomotorischen Beschwerden sind 14,7% der Frauen in der Postmenopause betroffen. Das haben kanadische Forscherinnen in einer Subgruppenanalyse der WARM-Studie herausgefunden.

Depressive Senioren fahren besonders riskant

Beim Autofahren machen ältere Depressive häufiger eine Vollbremsung, gehen öfter zu schnell in Kurven und halten sich seltener an Tempolimits als Senioren ohne Depression. Offenbar scheint eine Depression eine riskante Fahrweise im Alter zu verstärken.

Verhaltenstherapie plus Stimulanz reduziert Binge Eating

Die Kombination von kognitiver Verhaltenstherapie plus Lisdexamfetamin bringt Personen mit Binge-Eating-Störung deutlich häufiger in Remission als die jeweiligen Einzeltherapien. Zudem nimmt das Gewicht der Betroffenen spürbar ab.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.